MRVI · Maravai Lifesciences Holdings, Inc.
$5.70
-0.08 (-1.38%)
At close · Aug 14
Market Cap
$1.48B
Shares
259.67M
Maravai Lifesciences Holdings, Inc. Earnings Call Transcripts
Every quarterly earnings call for Maravai Lifesciences Holdings, Inc. (MRVI) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼6.6%
$191.26M
$44.47M
'22 Q3
22-11-02
▼10.4%
$204.71M
$37.63M
'22 Q4
23-02-22
▼67.7%
$79.03M
−$67,000
'23 Q1
23-05-08
▼71.6%
$68.91M
−$6.54M
'23 Q2
23-08-07
▼65%
$66.86M
−$6.46M
'23 Q3
23-11-07
▼63.8%
$74.14M
−$105.96M
'23 Q4
24-02-22
▼18.8%
$64.18M
−$12.08M
'24 Q1
24-05-08
▲0.7%
$69.42M
−$9.79M
'24 Q2
24-08-07
▲3.2%
$69.03M
−$97.07M
'24 Q3
24-11-07
▼23.7%
$56.56M
−$25.91M
'24 Q4
25-02-25
▼27%
$46.85M
−$29.95M
'25 Q1
25-05-12
▼31.7%
$47.40M
−$39.59M
'25 Q2
25-08-11
▼39.7%
$41.63M
−$25.56M
'25 Q3
25-11-06
▼11.8%
$49.87M
−$35.68M
'25 Q4
26-02-25
▲40.5%
$65.84M
−$3.73M
'26 Q1
26-05-07
LATEST
▲8.5%
$51.44M
−$12.42M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Q2 2026 Maravai LifeSciences Earnings Conference Call
Confident tone
TriLink mRNA Growth
ModTail Adoption
Commercial Execution
Revenue
$51.44M
▲ 8.5% YoY Diluted EPS
$-0.08
Gross margin
40.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference in New York
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Maravai Lifesciences Holdings, Inc. Q1 FY2026 Earnings Call
Confident tone
TriLink revenue growth
Cygnus performance
ModTail adoption
Revenue
$65.84M
▲ 40.5% YoY Diluted EPS
$-0.02
Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
Maravai Lifesciences Holdings, Inc. Q4 FY2025 Earnings Call
Confident tone
2026 guidance and outlook
Adjusted EBITDA recovery
Trilink commercial execution and CleanCap
Revenue
$49.87M*
▼ 11.8% YoY Gross margin
25.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Maravai Lifesciences Holdings, Inc. Q3 FY2025 Earnings Call
Positive tone
Nucleic Acid Products / TriLink Recovery
Product Innovation and Launches
Cost Restructuring and EBITDA Improvement
Revenue
$41.63M
▼ 39.7% YoY Diluted EPS
$-0.18
Gross margin
13.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Maravai Lifesciences Holdings, Inc. Q2 FY2025 Earnings Call
Positive tone
Nucleic Acid Production (NAP) / mRNA headwinds
Path back to profitability
CDMO business
Revenue
$47.40M
▼ 31.7% YoY Diluted EPS
$-0.27
Gross margin
16.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Maravai Lifesciences Holdings, Inc. Q1 FY2025 Earnings Call
Positive tone
China / BST export exposure
Tariffs and supply chain mitigation
Guide RNA / oligo and Molecular Assemblies integration
Revenue
$46.85M
▼ 27% YoY Diluted EPS
$-0.21
Gross margin
16.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Maravai Lifesciences Holdings, Inc. Q4 FY2024 Earnings Call
Cautious tone
High-volume CleanCap demand and customer inventory
New product launches (CleanScribe, etc.)
Flanders 2 facility and commercial pipeline
Revenue
$56.56M*
▼ 23.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Maravai Lifesciences Holdings, Inc. Q3 FY2024 Earnings Call
Cautious tone
Nucleic Acid Production (NAP) segment
Cost structure and commercial investment
Biologics Safety Testing (BST) softness
Revenue
$69.03M
▲ 3.2% YoY Diluted EPS
$-0.68
Gross margin
46.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Maravai Lifesciences Holdings, Inc. Q2 FY2024 Earnings Call
Positive tone
Flanders facility ramp-up
Margin and pricing dynamics
New product introductions (NPI)
Revenue
$69.42M
▲ 0.7% YoY Diluted EPS
$-0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Maravai Lifesciences Holdings, Inc. Q1 FY2024 Earnings Call
Positive tone
Nucleic Acid Production product innovation
Return to growth strategy and commercial team
Q1 financial results and cash position
Revenue
$64.18M
▼ 18.8% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Maravai Lifesciences Holdings, Inc. Q4 FY2023 Earnings Call
Positive tone
CleanCap pipeline expansion
Nucleic Acid Production segment
Biologics Safety Testing segment
Revenue
$74.14M*
▼ 63.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Maravai Lifesciences Holdings, Inc. Q3 FY2023 Earnings Call
Revenue
$66.86M
▼ 65% YoY Diluted EPS
$-0.05
▼ 114.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Maravai Lifesciences Holdings, Inc. Q2 FY2023 Earnings Call
Revenue
$68.91M
▼ 71.6% YoY Diluted EPS
$-0.05
▼ 109.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Maravai Lifesciences Holdings, Inc. Q1 FY2023 Earnings Call
Revenue
$79.03M
▼ 67.7% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Maravai Lifesciences Holdings, Inc. Q4 FY2022 Earnings Call
Revenue
$204.71M*
▼ 10.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Maravai Lifesciences Holdings, Inc. Q3 FY2022 Earnings Call
Revenue
$191.26M
▼ 6.6% YoY Diluted EPS
$0.34
▼ 22.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Maravai Lifesciences Holdings, Inc. Q2 FY2022 Earnings Call
Revenue
$242.73M
▲ 11.5% YoY Diluted EPS
$0.53
▲ 20.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Maravai Lifesciences Holdings, Inc. Q1 FY2022 Earnings Call
Revenue
$244.29M
▲ 64.8% YoY Diluted EPS
$0.50
▲ 108.3% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Maravai Lifesciences Holdings, Inc. Q4 FY2021 Earnings Call
Revenue
$228.44M*
▲ 132.3% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Maravai Lifesciences Holdings, Inc. Q3 FY2021 Earnings Call
Revenue
$204.81M
▲ 133.1% YoY Diluted EPS
$0.44
▲ 266.7% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Maravai Lifesciences Holdings, Inc. Q2 FY2021 Earnings Call
Revenue
$217.78M
▲ 364.3% YoY Diluted EPS
$0.44
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Maravai Lifesciences Holdings, Inc. Q1 FY2021 Earnings Call
Revenue
$148.21M
▲ 190.7% YoY Diluted EPS
$0.24
▲ 166.7% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
Maravai Lifesciences Holdings, Inc. Q4 FY2020 Earnings Call
Revenue
$98.35M*
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–24 of 24 earnings calls
Key facts
CIK
1823239
CUSIP
56600D107
13F (30d)
177 filings
173 filers
Visit website
Investor relations